379
Participants
Start Date
January 29, 2019
Primary Completion Date
December 20, 2019
Study Completion Date
December 20, 2019
EsoDuo Tab. 20/800mg
Nexium Tab. 20mg
Dong-A University Hospital, Busan
Kosin University Gospel Hospital, Busan
Soonchunhyang University Cheonan Hospital, Cheonan
Chungbuk National University Hospital, Cheongju-si
Hallym University Chuncheon Seonsim Hospital, Chuncheon
Daegu Catholic Hospital, Daegu
Keimyung University Dongsan Medical Center, Daegu
Yeungnam University Medicar Center, Daegu
Chungnam National University Hospital, Daejeon
Myongji Hospital, Goyang
Chonnam National University Hospital, Gwangju
Ajou University Hospital, Gyeonggi-do
Hanyang University Guri Hospital, Gyeonggi-do
Inje University ilsan Paik Hospital, Gyeonggi-do
Soonchunhyang University Bucheon Hospital, Gyeonggi-do
Wonkwang University Hospital, Iksan
Dongguk University IIsan Hospital, Ilsan
Gachon Gil Hospital, Incheon
Jeju National University Hospital, Jeju City
Chonbuk National University Hospital, Jeonju
Inje University Busan Paik Hospital, Pusan
Inje University Haeundae Paik Hospital, Pusan
Pusan National University Hospital, Pusan
Yangsan Pusan National University Hospital, Pusan
Asan Medical Center, Seoul, Seoul
Catholic University Seoul St. Mary's Hospital, Seoul
Chung Ang University Hospital, Seoul
Gangnam Severance, Seoul
Hanyang University Hospital, Seoul
Konkuk University Hospital, Seoul
Korea University Anam Hospital, Seoul
Korea University Guro Hospital, Seoul
Kyunghee Universtiy Hospital, Seoul
Samsung Seoul Hospital, Seoul
Seoul National University Hospital, Seoul
Severance Hospital, Seoul
Soonchunhyang University Seoul Hospital, Seoul
Wonju Severance Christian Hospital, Wŏnju
Lead Sponsor
Chong Kun Dang Pharmaceutical
INDUSTRY